MLLT1 Antikörper (C-Term)

Produktnummer ABIN5537117

Produktdetails anti-MLLT1 Antikörper

Target: MLLT1 (MLLT1, super elongation complex subunit (MLLT1))

Bindungsspezifität: AA 523-552, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MLLT1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This MLLT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 523-552 amino acids from the C-terminal region of human MLLT1.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: For WB starting dilution is: 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu MLLT1

Target: MLLT1 (MLLT1, super elongation complex subunit (MLLT1))

Andere Bezeichnung: MLLT1 (MLLT1 Produkte)

Synonyme: MGC84026 antikoerper, MLLT1 antikoerper, ENL antikoerper, LTG19 antikoerper, YEATS1 antikoerper, AA407901 antikoerper, BAM11 antikoerper, MLLT1, super elongation complex subunit antikoerper, myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 L homeolog antikoerper, myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 antikoerper, Mllt1 antikoerper, MLLT1 antikoerper, mllt1.L antikoerper, mllt1 antikoerper

Hintergrund: Chromosome band 11q23 is the site of translocations in myeloid and lymphoid acute leukemias, pediatric leukemias, and treatment-induced secondary acute myelogenous leukemia. The translocation breakpoints cluster in a restricted region of the HRX gene resulting in chimeric genes that encode an N-terminal portion of Hrx fused to various partner proteins. Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) is a nuclear protein with transcriptional transactivation properties that is fused to Hrx in t(11,19) leukemias. The minimal MLLT1 sequence required for transcription activation was narrowed to the C-terminal 90 amino acids.

Molekulargewicht: 62 kDa

Gen-ID: 4298

UniProt: Q03111